. Author manuscript; available in PMC: 2022 Oct 13.

Published in final edited form as: Exp Clin Psychopharmacol. 2019 Mar 28;27(6):536–551. doi: 10.1037/pha0000278

Table 3.

Smoking Abstinence Symptom Recovery Times Indexed from Personal Baseline with and without No-Quit Control Comparisons.

Smoking Abstinence Symptom	1^st Day SAS Mean No Longer Significantly Greater than Pre-Quit Baseline			1^st Day SAS Mean No Longer Significantly Greater than DQG Controls
	Placebo	NRT	Bupropion	Placebo	NRT	Bupropion
Anger	31	9	31	67	67	67
Anxiety	12	6	31	67	31	67
Depression	6	3	6	67	67	67
PANAS-NA	6	3	6	67	67	67
Craving	6	3	3	6	18	6

Note. The baseline comparisons indicate the 1^st post-quit day on which the SAS was no longer statistically significantly greater than 0 without return to significance at two or more later points in time; the mean of the last two pre-quit baseline levels as assessed by a two-sided t tests with p < .05. DQG control comparisons indicate the 1st Day SAS post-quit means for the treatment group are no longer significantly greater than the DQG controls without return to significance at two or more later points in time; using two-sided t tests with p < .05.